These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9659959)

  • 1. Maintenance electroconvulsive therapy for intractable Parkinson's disease.
    Wengel SP; Burke WJ; Pfeiffer RF; Roccaforte WH; Paige SR
    Am J Geriatr Psychiatry; 1998; 6(3):263-9. PubMed ID: 9659959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECT and Parkinson's disease revisited: a "naturalistic" study.
    Douyon R; Serby M; Klutchko B; Rotrosen J
    Am J Psychiatry; 1989 Nov; 146(11):1451-5. PubMed ID: 2817117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study.
    Pintor LP; Valldeoriola F; Fernández-Egea E; Sánchez R; Rami L; Tolosa E; Muñiz A; Martí MJ; Bernardo M
    J ECT; 2012 Jun; 28(2):87-91. PubMed ID: 22531200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease.
    Williams NR; Bentzley BS; Sahlem GL; Pannu J; Korte JE; Revuelta G; Short EB; George MS
    Acta Neurol Scand; 2017 Apr; 135(4):407-411. PubMed ID: 27241213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of ECT in patients with parkinsonism.
    Moellentine C; Rummans T; Ahlskog JE; Harmsen WS; Suman VJ; O'Connor MK; Black JL; Pileggi T
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):187-93. PubMed ID: 9608407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness.
    Oh JJ; Rummans TA; O'Connor MK; Ahlskog JE
    Am J Psychiatry; 1992 Feb; 149(2):271. PubMed ID: 1294061
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.
    Tramontana MG; Molinari AL; Konrad PE; Davis TL; Wylie SA; Neimat JS; May AT; Phibbs FT; Hedera P; Gill CE; Salomon RM; Wang L; Song Y; Charles D
    J Parkinsons Dis; 2015; 5(1):151-63. PubMed ID: 25613351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance electroconvulsive therapy for Parkinson's disease.
    Aarsland D; Larsen JP; Waage O; Langeveld JH
    Convuls Ther; 1997 Dec; 13(4):274-7. PubMed ID: 9437571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of Parkinsonism in depressed patients treated with ECT.
    Lebensohn ZM; Jenkins RB
    Am J Psychiatry; 1975 Mar; 132(3):283-5. PubMed ID: 1115272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia.
    Hausner L; Damian M; Sartorius A; Frölich L
    J Clin Psychiatry; 2011 Jan; 72(1):91-7. PubMed ID: 21208587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive therapy in Parkinsonian patients with the "on-off" syndrome.
    Ward C; Stern GM; Pratt RT; McKenna P
    J Neural Transm; 1980; 49(1-2):133-5. PubMed ID: 7441236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation and maintenance ECT: a review of recent research.
    Andrade C; Kurinji S
    J ECT; 2002 Sep; 18(3):149-58. PubMed ID: 12394534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.
    Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance ECT in Parkinson's disease.
    Fall PA; Granérus AK
    J Neural Transm (Vienna); 1999; 106(7-8):737-41. PubMed ID: 10907732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly: a prospective naturalistic study.
    Verwijk E; Comijs HC; Kok RM; Spaans HP; Tielkes CE; Scherder EJ; Stek ML
    Int Psychogeriatr; 2014 Feb; 26(2):315-24. PubMed ID: 24280446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Practice of Assessing Cognitive Function in Adults Receiving Electroconvulsive Therapy: Whom Are We Missing?
    Obbels J; Vanbrabant K; Bouckaert F; Verwijk E; Sienaert P
    J ECT; 2016 Jun; 32(2):99-103. PubMed ID: 26421675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.